PHP
PODD icon

Parkman Healthcare Partners’s Insulet PODD Stock Holding History

Parkman Healthcare Partners’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.9M Buy
156,561
+15,701
+11% +$3.95M 3.39% 4
2025
Q4 		$40M Buy
140,860
+24,622
+21% +$7.7M 3.81% 2
2025
Q3 		$35.9M Buy
116,238
+10,476
+10% +$3.28M 3.74% 4
2025
Q2 		$33.2M Sell
105,762
-24,752
-19% -$7.14M 3.82% 2
2025
Q1 		$34.3M Buy
130,514
+4,753
+4% +$1.29M 4.07% 1
2024
Q4 		$32.8M Sell
125,761
-33,928
-21% -$8.54M 4.37% 3
2024
Q3 		$37.2M Sell
159,689
-19,616
-11% -$4.03M 4.74% 2
2024
Q2 		$36.2M Buy
179,305
+88,356
+97% +$15.9M 4.85% 2
2024
Q1 		$15.6M Buy
90,949
+2,274
+3% +$424K 1.91% 14
2023
Q4 		$19.2M Buy
88,675
+46,650
+111% +$8M 2.71% 9
2023
Q3 		$6.7M Sell
42,025
-16,026
-28% -$3.59M 1.23% 28
2023
Q2 		$16.7M Buy
58,051
+29,307
+102% +$8.9M 2.9% 7
2023
Q1 		$9.17M Buy
28,744
+10,702
+59% +$3.17M 1.99% 18
2022
Q4 		$5.31M Buy
18,042
+988
+6% +$272K 1.41% 24
2022
Q3 		$3.91M Buy
17,054
+3,165
+23% +$793K 1.11% 28
2022
Q2 		$3.03M Buy
13,889
+1,218
+10% +$277K 1.11% 31
2022
Q1 		$3.38M Sell
12,671
-4,329
-25% -$1.06M 0.99% 37
2021
Q4 		$4.52M Sell
17,000
-17,340
-50% -$5.03M 1% 31
2021
Q3 		$9.76M Sell
34,340
-1,000
-3% -$285K 2.47% 13
2021
Q2 		$9.7M Buy
35,340
+4,171
+13% +$1.13M 2.12% 14
2021
Q1 		$8.13M Buy
31,169
+582
+2% +$156K 1.89% 17
2020
Q4 		$7.82M Sell
30,587
-1,916
-6% -$475K 2% 17
2020
Q3 		$7.69M Buy
32,503
+15,003
+86% +$3.16M 2.04% 17
2020
Q2 		$3.4M Buy
+17,500
New +$3.35M 0.96% 37

Other funds holding PODD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Parkman Healthcare Partners's PODD Position: Q1 2026 in Review

Parkman Healthcare Partners increased its Insulet (PODD) stake by 11% in Q1 2026, buying an estimated $3.95M and bringing the position to 156,561 shares worth $32.9M. The position accounts for 3.39% of the portfolio, ranked #4.

Parkman Healthcare Partners first reported a position in PODD in Q2 2020 and has held it in 24 quarters since. The position peaked at $40M in Q4 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Parkman Healthcare Partners held 156,561 shares of Insulet worth $32.9M as of Q1 2026.
  • Parkman Healthcare Partners bought 15,701 Insulet shares in Q1 2026, an estimated $3.95M.
  • Insulet made up 3.39% of Parkman Healthcare Partners's portfolio in Q1 2026, its #4 holding.
  • Parkman Healthcare Partners first reported a position in Insulet in Q2 2020 and has held it in 24 quarters since.
  • Parkman Healthcare Partners's Insulet position peaked at $40M in Q4 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.